As characterization of HSP profiles in clinically relevant settings may lead to development of specific new treatment strategies for cancer eradication, the present study was designed to assess the extracellular expression of HSPA1A/B and its potential effect on immune system response in patients undergoing treatment for prostate cancer. The gene discussed is HSP90B2P; the disease is prostate carcinoma.